Search

everythinglearnresearchcommunity

for

Search:↓

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.

Noggin promotes skin tumors by activating Wnt and Shh pathways.

Cetirizine is effective and safe for treating various allergies, with personalized dosing improving its use.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

New compounds with carborane showed anti-androgen effects similar to flutamide.

The document concludes that scientists created various steroids with different properties, including a more effective semi-synthetic vitamin D.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Chronic stress can reduce skin pigmentation.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

GPCRs are vital for wound healing by affecting cell growth and immune response.

Stress hormone CRF can cause hair loss by affecting hair growth cells and hormones.

Blocking TRPV3 may help treat itch in dry skin conditions.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Finasteride may improve prostate cancer treatment outcomes.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Drug repurposing shows promise for treating many medical conditions.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Phloroglucinol may help improve hair loss by promoting hair growth and reducing oxidative stress.